MW 292.4 Da, Purity >98%. p53 activator. Tricyclic thiophene derivative that binds to p53 and induces its accumulation in tumor cells. Prevents p53-HDM2 (MDM2) interaction in vitro and in vivo and affects p53 interaction with several negative regulators. Induces expression of p53 target genes and apoptosis in various tumor cell lines expressing wild-type p53.
1 25 dihydroxyvitamin D3 receptor, 25-dihydroxyvitamin D3 receptor, Beta-interferon, Fibroblast interferon, IFB, IFF, IFN-beta, IFNB 1, IFNB_HUMAN, IMD42, Interferon beta, Interferon beta 1 fibroblast, Interferon beta precursor, MGC129539, MGC96956, Member 1, NR1F3, NR1I1, Nuclear receptor ROR-gamma, Nuclear receptor RZR-gamma, Nuclear receptor subfamily 1 group F member 3, Nuclear receptor subfamily 1 group I member 1, PPP1R163, Protein phosphatase 1, regulatory subunit 163, RAR related orphan nuclear receptor variant 2, RAR related orphan receptor C, isoform a, RAR related orphan receptor gamma, RAR-related orphan receptor C, RORG_HUMAN, RZR GAMMA, RZRG, Retinoic acid binding receptor gamma, Retinoid-related orphan receptor-gamma, Rorc, TOR, VDR_HUMAN, Vitamin D (1,25- dihydroxyvitamin D3) receptor, Vitamin D hormone receptor, Vitamin D nuclear receptor variant 1, Vitamin D receptor, Vitamin D3 receptor
MW 292.4 Da, Purity >98%. p53 activator. Tricyclic thiophene derivative that binds to p53 and induces its accumulation in tumor cells. Prevents p53-HDM2 (MDM2) interaction in vitro and in vivo and affects p53 interaction with several negative regulators. Induces expression of p53 target genes and apoptosis in various tumor cell lines expressing wild-type p53.
Soluble in DMSO to 100 mM.
Soluble in ethanol to 25 mM.
p53 activator. Tricyclic thiophene derivative that binds to p53 and induces its accumulation in tumor cells. Prevents p53-HDM2 (MDM2) interaction in vitro and in vivo and affects p53 interaction with several negative regulators. Induces expression of p53 target genes and apoptosis in various tumor cell lines expressing wild-type p53.
This product is manufactured by BioVision, an Abcam company and was previously called 2469 RITA. 2469-25 is the same size as the 25 mg size of ab219379.
Interferon beta Vitamin D Receptor (VDR) and ROR gamma are important targets in immune and cellular regulation. Interferon beta with a mass of approximately 20000 Daltons acts as an antiviral cytokine and is produced by fibroblasts and epithelial cells. It is also known as IFN-β and plays a role in controlling viral infections. Vitamin D Receptor is a nuclear hormone receptor expressed in various body tissues including the intestine and bone. VDR's function involves binding to vitamin D which aids in maintaining calcium homeostasis and bone health. ROR gamma also known as RORC (RAR-related orphan receptor C) weighs around 58000 Daltons and is expressed in immune cells particularly affecting the development of Th17 cells.
Interferon beta modulates the immune response by activating antiviral genes and inhibiting viral replication. It is not part of a complex but acts directly to upregulate MHC class I expression. Vitamin D Receptor plays a role in gene transcription by forming complexes with other transcription factors influencing the expression of genes responsible for calcium absorption. ROR gamma regulates genes involved in metabolic processes and lymphoid tissue development essential in the differentiation of Th17 cells. These Th17 cells are pivotal in inflammatory responses highlighting the ROR gamma's role in immune function.
Interferon beta participates in the JAK-STAT signaling pathway activating genes responsible for antiviral defense. It also interacts with proteins such as STAT1 and STAT2 which further amplify the immune response. The Vitamin D Receptor engages significantly in the vitamin D endocrine system which affects numerous signaling pathways including calcium and phosphate metabolism. VDR's interactions with proteins like RXR coactivators enable various gene regulations linked to bone mineralization. ROR gamma is integral to the IL-6 signaling pathway impacting the immune system through interactions with proteins like IL-17 which drive pro-inflammatory responses.
Interferon beta plays a therapeutic role in managing multiple sclerosis by downregulating inflammation in the central nervous system. In this context it interacts with proteins such as IL-10 to modulate immune responses. Vitamin D Receptor is linked to bone disorders like osteoporosis where insufficient vitamin D levels can lead to decreased calcium absorption implicating proteins such as osteocalcin. ROR gamma's influence on the differentiation of Th17 cells connects it to autoimmune disorders like rheumatoid arthritis where excessive inflammatory responses occur. Understanding these target-protein relationships contributes to developing targeted therapies for these conditions.
We are dedicated to supporting your work with high quality reagents and we are here for you every step of the way should you need us.
In the unlikely event of one of our products not working as expected, you are covered by our product promise.
Full details and terms and conditions can be found here:
Terms & Conditions.
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com